KMT2A and acute myeloid leukemia: In MLL-AF9 expressing murine myeloid blasts, perturbation of ATR resulted in terminal differentiation in a similar manner to ATM inhibition (described above) (26), suggesting that like with ATM inhibitors, ATR inhibitors will be effective against this subgroup of AML.